Skip to main content
 
Previous Pause Next

What if…

  • Patients could benefit from a medicine prior to marketing approval or commercial availability?
  • A patient lives in a country where a much needed medicine may never be available?
  • A clinical trial participant needs access to the therapy after they exit the trial?
  • There is a drug shortage or discontinuation?

Idis has the answer.

  • Fully compliant solutions that enable access to medicines prior to approval and launch.
  • Access following clinical trials and the transition of patients to commercial supply.
  • Options when there is a discontinuation or drug shortage.
For patients: Access to medicines for unmet medical needs
For physicians: Timely access to medicines for your patients
For pharmacists: Access to therapeutic options when availability is a challenge
For pharmaceutical and biotechnology companies: Meeting global patient demand
Patients
Physicians
Pharmacists
Companies

Managed Access Programs can provide access to life-saving treatment

Watch the Managed Access Programs overview animation now

Recent News

10 ways to optimise patient access through the product life cycle with Managed Access Programmes
Pharmaceutical Marketing Europe

Idis employees make extraordinary effort for the RCF on Rare Disease Day
Press Release

Suzanne Gagnon, M.D. joins Idis as Chief Medical Officer
Press Release

Podcasts

Learn how managed access programs can be used to transition clinical trial patients to commercial supply   

Listen now

INSIGHTS on Access

Sign up for our newsletter “Insights on Access” and get all the latest and greatest information on Managed Access Programs and more…

Sign up

Upcoming Events

New York Pharma Forum 
May 22, 2013
New York, NY

American Society of Clinical Oncology (ASCO)
May 31 - Jun. 4, 2013
Chicago, IL 

Contact solutions@idispharma.com